RESULTS The analysis of the selected studies emphasized that GLP-1 RAs have an impact on headache management and other neurological conditions
The recently published SURPASS-2 has been conducted in order to compare the efficacy and safety of the three doses of tirzepatide with the GLP-1 agonist semaglutide at an injectable dose of 1 mg in patients with T2DM inadequately controlled with metformin monotherapy
If you lose more than 5% of your body weight in the first three to four months on an obesity medication, then youre more likely to maintain that body weight after 12 months, reports Dr
Ultrapure berberine: at least 97% pure berberine hydrochloride
Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus
In addition to purportedly helping with weight loss, these products often claim to help improve insulin sensitivity, blood sugar management, gut health and inflammation, says Aravamudhan